SenzaGen’s Newsletter July 2021
Click image to read the newsletter.
Entries by Julia Li
Webcast: Positive scientific ESAC opinion on GARD®skin – paving the way for OECD validation and opens new commercial opportunities
CEO Axel Sjöblad and Chief Scientist Henrik Johansson comment on the recently published ESAC opinion.
Applicability domain of the GARD™skin Medical Device test for in vitro skin sensitization testing of medical devices
Poster presented at SOT 2021 Joshua Schmidt, Ron Brown and Rose-Marie Jenvert SenzaGen Inc., Raleigh, NC, USA, Risk Science Consortium LLC, Arnold, MD, USA, SenzaGen AB, Lund, Sweden. Download a […]
Quantitative Sensitizing Potency Assessment Using GARD™skin Dose-Response
Poster presented at SOT 2021 Henrik Johansson, Robin Gradin, Andy Forreryd, Joshua Schmidt SenzaGen AB, Lund, Sweden. SenzaGen Inc., Raleigh, NC. Download a copy Conclusion As an adaptation from […]
GARDskin and GARDpotency: a proof of concept study to investigate the applicability domain for agrochemical formulations
Joint poster with Corteva, Presented at the 2021 SOT Virtual Conference M. Corvaro, J. Henriquez, R. Settivari, U.T. Mattson, S. Gehen | Corteva Agriscience Italia, Rome, ITA; Corteva Agriscience, Indianapolis, IN, […]
SOT 2021 Recap: Spotlight on Dose-Response and the MDCPSS Best Overall Abstract Award Winner 🏅
SenzaGen had a busy program at SOT 2021. To highlight our expanding capabilities in in vitro skin toxicology, we took part in several activities and presented our novel assays for quantitative skin […]
Applicability of GARD™skin for Accurate Assessment of Challenging Substances in the Context of Skin Sensitization Testing
Poster presented at ACT 2020 J. Schmidt, A. Forreryd, H. Johansson, J. Li, A. Johansson SenzaGen, Inc., Raleigh, NC, USA, SenzaGen AB, Lund, Sweden Link to the poster Conclusion […]
Dose-Response Analysis in GARD™ for Assessment of Skin Sensitizer Potency
Poster presented at ACT 2020 J. Schmidt, A. Forreryd, R. Gradin, H. Johansson. SenzaGen Inc., Raleigh, NC., SenzaGen AB, Lund, Sweden. Link to the poster Conclusion As an adaptation […]
Exploration of the GARD applicability domain – Skin sensitization assessment of UVCBs
Poster presented at Eurotox 2018 in collaboration with Lubrizol Download a copy U. I.Torstensdotter Mattson1, C. Humfrey2, O. Larne1, H. Johansson1, L. Sweet3 1SenzaGen, Lund, Sweden, 2Lubrizol, Derbyshire, United Kingdom, […]
